Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The genetic test maps 14 distinct metabolic pathways and analyzes 49 peptides to provide 150+ personalized insights about how your body responds to semaglutide and other GLP-1 therapies
Resources: Ying-Shi Zhang, Yi-Nuo Wang
Key Takeaways Prescribers and pharmacies will submit prior authorization requests and claims to a CMS contractor, not Part D plans or their PBMs Detailed conditions for beneficiary eligibility specified Patients will have a copay of $50, but pharmacy reimbursement details remain to be specified Background on the BALANCE Model CMS announced the BALANCE Model in December of last year, in which CMS will negotiate directly with manufacturers on behalf of Part D plan sponsors and state Medicaid agencies for more favorable costs and terms for GLP-1 medications
Wegovy prescriptions issued through myBMI are dispensed by the partner pharmacy, Epharm NI
US$ 24.84
US$ 25.20
US$ 20.95
US$ 28.10
US$ 26.31
US$ 20.97
US$ 20.85
US$ 23.64
US$ 22.20
